Comments on: Invitrogen Corporation Expands Cellular Assay Capabilities, To Acquire Sentigen Holding Corp.; Proprietary Tango(TM) and Cell Division Arrest Technologies Complement Invitrogen’s Broad Assay Technology Platform

Comments on: Invitrogen Corporation Expands Cellular Assay Capabilities, To Acquire Sentigen Holding Corp.; Proprietary Tango(TM) and Cell Division Arrest Technologies Complement Invitrogen’s Broad Assay Technology Platform http://www.bioscreening.net/2006/09/04/invitrogen-corporation-expands-cellular-assay-capabilities-to-acquire-sentigen-holding-corp-proprietary-tangotm-and-cell-division-arrest-technologies-complement-invitrogens-broad-assay-technology-plat/ BioScreening news and events hourly 1 http://wordpress.org/?v=3.3